Previous 10 | Next 10 |
SAN DIEGO, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference: HC Wainwright BIOCONNECT Virtual Conference Presentation will be ava...
SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming panel at the Longwood Healthcare Leaders Winter Conference: January 6 th at 11:50 am...
The last week of the year is turning out to be a rough one for many COVID-19 related stocks. Shares of Co-Diagnostics (NASDAQ: CODX) were sinking 12.4% for the week as of the market close on Thursday. Ocugen (NASDAQ: OCGN) was down 5.5% after plunging as much as 19.2% earlie...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NRx Pharmaceuticals (NASDAQ: NRXP ) stock is advancing in early trading today after the company announced that it was seeking breakthrough therapy designation from the U.S. Food and Drug Administration for its Covid-1...
Sorrento Therapeutics (NASDAQ:SRNE) announces that initial testing of COVISTIX on recombinant N proteins demonstrated its ability to detect the Omicron variant, in addition to detecting the original SARS-CoV-2 virus and other major variants of concern (VoCs) such as the delta and delta-p...
COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and all of its major variants of concern (VoCs); COVISTIX has the potential to be a “Best-in-Class” rapid COVID-19 virus antigen detection test: Comparative studies with...
Sorrento Therapeutics' (NASDAQ:SRNE) subsidiary, Sorrento Therapeutics Mexico executed a second contract with a large distributor for the sale and distribution of up to 10M COVISTIX tests for the Mexican market. Earlier, Sorrento Mexico had signed a contract with a leading local dis...
Sorrento Therapeutics' (NASDAQ:SRNE) Mexican subsidiary has executed a second contract with a large distributor for the sale and distribution of up to 10 million COVISTIX tests for the Mexican market. SRNE previously announced that Sorrento Mexico had signed a contract with a local distributo...
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its subsidiary, Sorrento Therapeutics Mexico (“Sorrento Mexico”), has executed a second contract with a large distributor for the s...
The FDA has authorized Sorrento Therapeutics' (NASDAQ:SRNE) IND application for a phase 1b trial of STI-1386 (Seprehvec) for oncolytic virus in patients with relapsed or refractor solid tumors. "Seprehvec allows for locoregional immune stimulation at the tumor site while potentially mini...
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...